NSTC First Friday Series- R&D Financing from your Favorite Uncle – Sam: Access Government Funds to Advance your Product
Friday, December 6 2013
12:30 pm – 2:00 pm
Location: McLane Law Firm, 300 TradeCenter, 7th Floor, Woburn, MA
Research and development costs can rapidly deplete resources and bring commercial advancement of a new product to a standstill. The U.S. government invests $5 billion per year in research and development in the biosciences industry – a little known funding pool for both entrepreneurs and larger businesses looking to accelerate and scale up product development efforts. At this NSTC First Friday seminar and networking event, experienced procurement consultant Rick Agopsowicz will discuss specific areas of government interest and provide recommendations on how to compete successfully for these non-dilutive investment funds.
Name: Richard (Rick) “A to Z” Agopsowicz
Title: Managing Director
Company: Capital Edge Consulting, Inc.
Bio: Mr. Agopsowicz has had long-term demonstrated success in developing and implementing programs to increase client revenue in both existing and adjacent markets and offerings. Prior to joining Capital Edge, he spent more than 10 years in government procurement consulting as a senior executive at a leading national consulting firm, and 30 years with the Department of Defense. With over 40 years of relevant experience in defense, intelligence, civil and State & Local government operations and procurement across: biotechnology & life sciences; health and human services; energy, IT systems; special security; special technical intelligence & operations; and major combat systems, Mr. Agopsowicz brings substantial specialized expertise to developing and implementing successful client business strategies across a broad spectrum.
Cost for Members and Non-members
Capital Edge assists clients in opportunity identification, pursuit, and execution in both existing and adjacent offerings/market areas by providing Business Strategy, Business Development & Research, and Capture Expertise to help formulate and manage new pipelines, as well as pursue and execute new opportunities. The company provides specialized capabilities to help deal with the complex U.S. government regulatory and compliance landscape from the business planning phases through execution and closeout.